Myomo, Inc.

MYO ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $14.1M $24.4M $6.9M $5.3M $15.5M $12.2M $4.5M $6.5M
Accounts Receivable $4.1M $3.8M $2.4M $1.9M $2.0M $924.9K $424.3K $382.3K
Inventory $3.1M $3.2M $1.8M $1.4M $808.3K $707.1K $439.5K $256.1K
Total Current Assets $27.6M $32.8M $13.7M $9.2M $19.1M $14.4M $6.1M $7.9M
Property, Plant & Equipment $2.2M $1.3M $175.8K $194.3K $275.3K $95.0K $155.0K $187.5K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $38.6M $42.2M $14.6M $10.2M $20.1M $14.7M $6.6M $8.3M
Liabilities
Accounts Payable $1.5M $1.2M $1.1M $569.7K $723.4K $180.5K $450.1K $426.7K
Total Current Liabilities $8.3M $10.2M $5.5M $3.6M $4.3M $2.9M $3.9M $1.9M
Long-Term Debt $11.2M $0 — — — — $889.0K —
Total Liabilities $27.2M $17.5M $5.6M $3.8M $4.7M $3.1M $4.8M $1.9M
Stockholders' Equity
Retained Earnings $-118.7M $-103.1M $-96.9M $-88.8M $-78.1M $-67.7M $-56.1M $-45.3M
Total Stockholders' Equity $11.4M $24.7M $9.0M $6.4M $15.4M $11.6M $6.4M $6.4M
← Newer Page 1 of 2 Older →